Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Setiyono, Agus ^a   Budiyati, Akterono D ^a   Purwantomo, Sigit ^a   Anggelia, Madonna R ^a   Fanany, Ismail ^a   Wibowo, Gunawan A ^a   Bachtiar, Indra ^a   Utama, Andi ^a   Tai, Susan ^a  

^a Mochtar Riady Institute for Nanotechnology   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 4; RECOMBINANT ALPHA FETOPROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; IL2 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 2; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; ADULT; APOPTOSIS; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; PROTEIN TERTIARY STRUCTURE; SECRETION;

ADULT; ALPHA-FETOPROTEINS; ANTIGENS, CD; APOPTOSIS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MONOCYTES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

EID: 78651407122     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-4     Document Type: Article

References (17)

1. Mizejewsky GJ. Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunol Immunother 2009, 58:159-70. 10.1007/s00262-008-0548-8, 18612637.
2. Morinaga T, Sakai M, Wegmann TG, Tamaoki. Primary structures of human a-fetoprotein and its mRNA. Proc Natl Acad Sci USA 1983, 80:4604-8. 10.1073/pnas.80.15.4604, 384092, 6192439.
3. Alisa A, Ives A, Pathan AA, Navarrete CV, Williams R, Bertoletti A, Behboudi S. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Clin Cancer Res 2005, 11:6686-94. 10.1158/1078-0432.CCR-05-0382, 16166448.
4. Um SH, Catherine M, Akeel A, Annette RI, John K, Roger W, Antonio B, Shahriar B. Alpha Fetoprotein impairs APC function and induces their apoptosis. J Immunol 2004, 173:1772-8.
5. Posypanova GA, Gorokhovets NV, Makarov VA, Savvateeva LV, Kireeva NN, Severin SE, Severin ES. Recombinant alpha-fetoprotein C-terminal fragment: the new recombinant vector for targeted delivery. J Drug Target 2008, 16:321-8. 10.1080/10611860801927721, 18446611.
6. Sigal LJ, Reiser H, Rock KL. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J Immunol 1998, 161:2740-5.
7. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998, 16:111-35. 10.1146/annurev.immunol.16.1.111, 9597126.
8. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001, 58:4-43.
9. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004, 22:307-28. 10.1146/annurev.immunol.22.012703.104533, 15032580.
10. Miga A, Masters S, Gonzalez M, Noelle RJ. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000, 29:111-4. 10.3109/08820130009062292, 10854177.
11. Zobywalsky A, Javorovic M, Frankenberger B, Pohla H, Kremmer E, Bigalke I, Schendel DJ. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70. J Transl Med 2007, 5:18. 10.1186/1479-5876-5-18, 1858682, 17430585.
12. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001, 167:5067-76.
13. Leong SSJ, Middelberg APJ. The refolding of different α-fetoprotein variants. Protein Sci 2006, 15:2040-50. 10.1110/ps.062262406, 2242608, 16882993.
14. Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD, Dahm P, Niedzwiecki D, Gilboa E, Vieweg J. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002, 109:409-17. 150859, 11828001.
15. Vollmer CM, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride H, Glaspy J, Economouz JS. -Fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res 1999, 59:3064-7.
16. Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. Cancer Res 1999, 59:3134-42.
17. Ghanekar S, Bhatia S, Ruitenberg JJ, Dela Rosa C, Disis ML, Maino VC, Maecker HT, Waters CA. Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors. J Immunother Based Ther Vaccines 2007, 5:7.